1. Home
  2. AZTR vs GITS Comparison

AZTR vs GITS Comparison

Compare AZTR & GITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Azitra Inc

AZTR

Azitra Inc

HOLD

Current Price

$0.28

Market Cap

3.2M

Sector

Health Care

ML Signal

HOLD

GITS

Global Interactive Technologies Inc.

HOLD

Current Price

$2.07

Market Cap

2.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZTR
GITS
Founded
2014
2018
Country
United States
South Korea
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2M
2.8M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
AZTR
GITS
Price
$0.28
$2.07
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
1.3M
4.1M
Earning Date
02-23-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,867.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$0.66
52 Week High
$3.92
$5.06

Technical Indicators

Market Signals
Indicator
AZTR
GITS
Relative Strength Index (RSI) 43.78 82.57
Support Level $0.26 $0.73
Resistance Level $0.36 $2.99
Average True Range (ATR) 0.03 0.28
MACD 0.00 0.17
Stochastic Oscillator 26.01 58.66

Price Performance

Historical Comparison
AZTR
GITS

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About GITS Global Interactive Technologies Inc.

Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.

Share on Social Networks: